Clinical Trial Update: Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjunctive levetiracetam, lacosamide, and ketamine for refractory status epilepticus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Status Epilepticus

Drugs mentioned

• Ketamine (ketamine)
• LEVETIRACETAM (levetiracetam)
• Lacosamide (Lacosamide)

Snippet

Sponsor: Mid-Atlantic Epilepsy and Sleep Center, LLC | Conditions: Epilepsy, Status Epilepticus | Phase 3 | Status: WITHDRAWN